Literature DB >> 35711122

Cerebellious abscesses caused by Nocardia farcinica in an immunocompromised patient.

D Sánchez-Ramos, E Vega-Torres, C Irles-Vidal, J Colomina-Rodríguez1.   

Abstract

Entities:  

Keywords:  Nocardia farcinica; brain abscess

Mesh:

Year:  2022        PMID: 35711122      PMCID: PMC9333111          DOI: 10.37201/req/034.2022

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   2.515


× No keyword cloud information.
Sir, Nocardia farcinica is a Gram-positive aerobic bacillus that can form branched pseudohyphae [1]. Culture in non-selective media requires 48-72 hours of incubation for visualization of colonies, which present a chalky white or orange appearance, with a slightly cottony appearance due to abundant aerial filaments [2]. Like other species of Nocardia, it is characterized by being present in the soil and can be transmitted to man by direct inhalation or by contaminated particles. In 39% of hospitalized patients, the infection commonly manifests as pulmonary disease, although the lesions are not always easily detectable. It is estimated that 9% of Nocardia infections lead to a brain abscess, with N. farcinica being the most frequent specie [3]. 82-year-old female patient who describes cervical pain radiating to occipital area, dysarthria, general weakness and drowsiness to mild stimuli is initially admitted to our Emergency Department. The patient presented history of high blood pressure, dyslipidemia, hearing loss and with a recent temporal arteritis diagnosis. Currently under oral treatment with valsartan 80 mg/day, acetylsalicylic acid 100mg/day, prednisone 30mg/day and methotrexate 2.5mg/week. On physical examination, the pain worsens with cervical mobilization. Neck stiffness was not observed. Preliminary laboratory evaluation showed CRP of 1.9 mg/L, leukocytes of 9.79x109/L and hematocrit of 30%, with no other findings of interest. The emergency evaluation concluded with a chest x-ray with no abnormal findings. The patient required hospital admission for brain magnetic resonance imaging (MRI). This study revealed the presence of multiple pseudonodular images of cystic appearance with peripheral gadolinium uptake in the posterior fossa, significant diffusion restriction, and slight mass effect and perilesional edema (Figure 1).
Figure 1

Brain MRI. A) T1 in presurgical axial section with polylobulated peripheral uptake with contrast. B) sequence of diffusion in presurgical axial section with clear restriction of the abscess. C) T1 postsurgical axial section with minimal contrast uptake. D) postsurgical diffusion sequence with almost total absence of restriction.

Brain MRI. A) T1 in presurgical axial section with polylobulated peripheral uptake with contrast. B) sequence of diffusion in presurgical axial section with clear restriction of the abscess. C) T1 postsurgical axial section with minimal contrast uptake. D) postsurgical diffusion sequence with almost total absence of restriction. Suspecting cerebellar abscesses, the patient underwent craniotomy with evacuation of purulent material from different cavities and partial excision of the capsule. Samples were collected and sent to the Pathological Anatomy unit and Microbiology laboratory. Given the possibility of an infectious condition, treatment with methotrexate was withdrawn and empirical treatment with cefotaxime, vancomycin, and metro-nidazole was started. The anatomopathological study of the drained material ruled out the existence of neoplastic cells. Weak Gram-positive branching bacilli was observed under direct microscopic examination after Gram staining of the abscess sample sent to Microbiology (Figure 2 A). At 72 hours of culture, the growth of small dull white dotted colonies was detected (Figure 2 B) on blood agar that, as the days of incubation passed, acquired a salmon color. The isolate was identified with a high degree of confidence (score = 2.1) using MALDI-TOF technology (Bruker®) as Nocardia farcinica. Approximately 75% of N. farcinica isolates may be resistant to third-generation cephalosporins [4], so intravenous treatment with cotrimoxazole 800/160mg/8h and amikacin 1g/24h was decided until the sensitivity study was obtained. antibiotic.
Figure 2

A) Gram stain of abscess sample: branched Gram-positive bacilli. B) Abscess cultures after 72 hours and C) 5 days of incubation at 37ºC in aerobic conditions.

A) Gram stain of abscess sample: branched Gram-positive bacilli. B) Abscess cultures after 72 hours and C) 5 days of incubation at 37ºC in aerobic conditions. The antimicrobial susceptibility study performed by microdilution (SensititreTM RAPMYCOI, Thermo Scientific®) showed MICs, which were interpreted according to CLSI criteria [5] as resistant (ceftriaxone >64 mg/L; imipenem 16 mg/L; ciprofloxacin >4 mg/L) or susceptible (amikacin <1 mg/L; line-zolid 2 mg/L; cotrimoxazole 38/2 mg/L). Twelve days after intervention, neurologic examination was within normal limits overall, with the patient remaining conscious with no additional neurological changes. Hospital discharge was decided to continue with outpatient follow-up and oral treatment with cotrimoxazole 800/160 mg (every 12 h) for 12 months. Cerebral nocardiosis can occur even in immunocompetent patients, but the highest incidence occurs in immunocompromised patients, such as those treated with corticosteroids or transplant patients, being potentially fatal despite the use of antibiotics and abscess drainage [6]. In recent years, the mortality rate for N. farcinica in disseminated infection is estimated at around 39% [7]. The combination of abscess evacuation by craniotomy and administration of antibiotics, being cotrimoxazole the drug of choice, gives very good results for patients with Nocardia brain abscess. However, antibiotics must be adjusted according to the sensitivity profiles tested [8], even though a high susceptibility of Nocardia farcinica to cotrimoxazole, amikacin, and linezolid has been reported in Spain [4], resistance to cotrimoxazole close to 54% has been documented in other countries [9].
  8 in total

1.  Lung nodules and retinal lesions in an immunocompromised patient.

Authors:  Oscar Morado-Aramburo; Brenda G Delgado-Ávila; Sergio A Calderón-Campas; Laura M Badel-Ramos
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2019-08-22

2.  Epidemiology and in vitro antimicrobial susceptibility of aerobic Actinomycetales in a clinical setting.

Authors:  Llanos Salar-Vidal; Marta Martín-García; Alicia Macías-Valcayo; Ana Ponz; Jaime Esteban
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2021-03-31

3.  Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.

Authors:  Lei Huang; Xingchun Chen; Heping Xu; Liying Sun; Chen Li; Wenchen Guo; Lili Xiang; Guolan Luo; Yancao Cui; Binghuai Lu
Journal:  Diagn Microbiol Infect Dis       Date:  2018-12-29       Impact factor: 2.803

Review 4.  Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient.

Authors:  Jonathan M Budzik; Mojgan Hosseini; Alexander C Mackinnon; Jerome B Taxy
Journal:  Surg Infect (Larchmt)       Date:  2012-05-21       Impact factor: 2.150

5.  Nocardial brain abscess.

Authors:  Yu-Jun Lin; Ka-Yen Yang; Jih-Tsun Ho; Tao-Chen Lee; Hung-Cheng Wang; Feng-Wen Su
Journal:  J Clin Neurosci       Date:  2009-12-14       Impact factor: 1.961

Review 6.  Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature.

Authors:  Theodora Anagnostou; Marios Arvanitis; Themistoklis K Kourkoumpetis; Athanasios Desalermos; Herman A Carneiro; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

7.  Nocardia Farcinica Brain Abscess in an Immunocompetent Old Patient: A Case Report and Review of Literature.

Authors:  Dinesh Mohan Chaudhari; Pushpendra Nath Renjen; Raman Sardana; Hena Butta
Journal:  Ann Indian Acad Neurol       Date:  2017 Oct-Dec       Impact factor: 1.383

8.  Nocardia farcinica as a cause of chronic meningitis - case report.

Authors:  Anna Moniuszko-Malinowska; Piotr Czupryna; Izabela Swiecicka; Henryk Grześ; Agnieszka Siemieniako; Sambor Grygorczuk; Eugeniusz Tarasów; Sławomir Pancewicz
Journal:  BMC Infect Dis       Date:  2020-01-17       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.